PLUS vs WST · P/E 17, rev $2.07B vs P/E 35, rev $2.89B
ePlus inc (PLUS) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
ePlus inc (PLUS) is a software - application company listed on NASDAQ.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported PLUS revenue for 2025-03-31 was $2.07B. Net income was $108.0M. Revenue was down 7.0% from 2024-03-31 to 2025-03-31. PLUS currently screens at market cap $2.10B and trailing P/E 17.1.
Latest reported WST revenue for 2024-12-31 was $2.89B. Net income was $492.7M. Revenue was down 1.9% from 2023-12-31 to 2024-12-31. WST currently screens at market cap $15.97B and trailing P/E 34.8.
PLUS currently screens at market cap $2.10B and trailing P/E 17.1. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the PLUS and WST stock pages for the full models.
Not investment advice.